This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
Save the dateMarch 17–19, 2025 | Milan, Italy

Neurocentrx Pharma Ltd


Pioneering biopharma company Neurocentrx have developed an abuse-deterrent, oral-ketamine therapy for Treatment-Resistant Depression(TRD), which has the potential to provide a convenient, cost-effective means to reduce the high medical morbidity, socio-economic burden, and individual patient suffering associated with TRD